Schedule 13G ownership disclosure

CORREVIO PHARMA CORP

Security class unavailable · CUSIP: 22026V105

Event date: 2018-06-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,627,954
Percent of class
13.2700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-18-001615
Form type
SC 13G/A
Filer
Correvio Pharma Corp.
CIK
CIK 1036141
Filed
Jul 03, 2018
Reporting period
Jun 29, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub